共 32 条
[1]
Buchacher A., Iberer G., Purification of intravenous immunoglobulin G from human plasma-aspects of yield and viral safety, Biotechnol. J, 1, pp. 148-163, (2006)
[2]
Brorson K., Norling L., Current and future approaches to ensure the viral safety of biopharmaceuticals, Dev. Biol, 118, pp. 17-29, (2004)
[3]
Preuss T., Kamstrup S., Kyvsgaard N.C., Nansen P., Et al., Comparison of two different methods for inactivation of viruses in serum, Clin. Diagn. Lab. Immunol, 4, pp. 504-508, (1997)
[4]
Burnouf T., Radosevich M., Nanofiltration of plasma-derived biopharmaceutical products, Haemophilia, 9, pp. 24-37, (2003)
[5]
Zolton R.P., Padvelskis J.V., Kaplan P.M., Removal of hepatitis B virus infectivity from human gamma-globulin prepared by ion-exchange chromatography, Vox Sang, 49, pp. 381-389, (1985)
[6]
Uemura Y., Yang Y.H.J., Heldebrant C.M., Takechi Y., Yokoyama K., Inactivation and elimination of viruses during preparation of human intravenous immunoglobulin, Vox Sang, 67, pp. 246-254, (1994)
[7]
Evengard B., Ehrnst A., von Sydow M., Pehrson P.O., Et al., Effect of heat on extracted HIV vira
[8]
infectivity and antibody using the filter paper technique of blood sampling, AIDS, 3, pp. 591-595, (1989)
[9]
Nowak T., Gregersen J.P., Klockmann U., Cummins L.B., Hilfenhaus J., Viral safety of human immunoglobulins: Efficient inactivation of hepatitis C and other human pathogenic viruses by the manufacturing procedure, J. Med. Virol, 36, pp. 209-216, (1992)
[10]
Horowitz B., Lazo A., Grossberg H., Page G., Et al., Virus inactivation by solvent/detergent treatment and the manufacturing of SD-plasma, Vox Sang, 74, pp. 203-206, (1998)